Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Vote in favor of Your #1 4\u00d74 SUVs - 2Israel approves 19 new West Bank settlements in major annexation push
- 3Churches and politicians in South Sudan call for 'lasting peace' in Easter messages
- 4Wisconsin judge sends Slender Man attacker back to mental health institution after group home escape
- 5Photos: Presidential turkey pardons — a look back
- Collierville residents with no power as temperatures plunge
- ‘It’s Israeli policy’: Report reveals abuse of Palestinians in prisons
- Very good quality Greens All over The Planet
- Somalia set for 'historic' first offshore oil drilling
- Asia's Noteworthy Destinations: A Voyager's Aide
- Accomplishing Balance between fun and serious activities: Procedures for a Better Life
- Asia's migrant workers debate if Gulf jobs are worth deadly risk of Iran war
- Experience Is standing by: History's Most noteworthy Travelers
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
